Explore 3 Stock Ideas & Industry Insights Download Free Report

Forza Innovations Inc

Company price
0.0001 USD 0.00(0%)
Last update at 2026-11-18T21:00:00Z
VOLUME
3000000
Market Cap
0.25M

Momentum Score

…

Forza Innovations Inc. engages in the health-tech wearable performance business. It offers WarmUp series product line, including J4 Sport, J4 X, and J4 Fitbelt that are wearable back compression devices that are used to relax, warmup, loosen, or relax stiff and sore muscles. The company was formerly known as Genesys Industries, Inc. and changed its name to Forza Innovations Inc. in June 2021. Forza Innovations Inc. was incorporated in 2014 and is based in San Diego, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Forza Innovations Inc is an OTC Pink-listed microcap with limited public disclosure about its operations, products or revenue. Long-term growth drivers are not disclosed, so potential upside depends on the company establishing commercial traction or a clearer strategic direction and could appeal to investors seeking high-risk, early-stage exposure.
Key risks include sparse disclosure and low liquidity, potential for heavy shareholder dilution, absence of audited financial statements and execution and financing uncertainty typical of OTC microcap issuers.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
0.09M
Revenue Per Share
-
Gross Profit TTM
0.09M
Debt / Equity
-0.39
ROE
-
Net Debt
1.81M
ROCE
67.97%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Income before tax -4.76M -4.76M -2.70M -0.32M -0.32M
Net income -4.76M -4.76M -3.50M -0.46M -0.32M
Selling general administrative 0.98M 1.01M 1.81M 0.23M 0.23M
Selling and marketing expenses 0.03M - 0.11M - -
Gross profit 0.09M 0.09M 0.02M 0.21M 0.21M
Reconciled depreciation - 0.06M 0.04M 0.01M 0.07M
Ebit -3.13M - -1.90M -0.06M -0.03M
Ebitda -3.07M - -1.86M 0.01M -0.07M
Depreciation and amortization 0.06M - 0.04M 0.07M -
Operating income -0.93M -0.93M -1.90M -0.06M -0.02M
Other operating expenses 1.04M - 1.93M 0.63M -
Interest expense 1.62M 1.62M 0.53M 0.18M 0.18M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - 0.00M - - -
Net interest income - -1.79M -1.69M -0.04M -0.18M
Income tax expense 1.62M - 0.80M 0.14M -
Total revenue 0.11M 0.11M 0.03M 0.61M 0.61M
Total operating expenses 1.01M 1.04M 1.92M 0.23M 0.63M
Cost of revenue 0.03M 0.03M 0.00M 0.40M 0.40M
Total other income expense net -3.83M -2.04M -0.80M -0.26M -0.12M
Discontinued operations - - - 0.03M -0.03M
Net income from continuing ops - -4.76M -2.70M -3.17M -0.32M
Net income applicable to common shares - - -2.70M -3.14M -0.32M
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 0.09M 0.09M 0.46M 0.85M 0.85M
Intangible assets - - - 0.02M -
Other current assets - - 0.01M - 0.26M
Total liab 4.70M 4.70M 1.79M 0.79M 0.79M
Total stockholder equity -4.61M -4.61M -1.33M 0.06M 0.06M
Other current liab 2.78M 2.48M 0.81M 0.14M 0.27M
Common stock 1.42M - 0.22M 0.02M 0.02M
Capital stock - 1.43M 0.23M 0.04M 0.03M
Retained earnings -10.95M -10.95M -6.20M -0.35M -0.35M
Other liab - - - - 0.36M
Other assets 91.40M - 0.01M - 0.59M
Cash - 0.00M 0.30M 0.17M 0.17M
Total current liabilities 4.70M 4.70M 1.79M 0.43M 0.43M
Current deferred revenue 0.30M - - - -
Net debt 1.81M 1.81M 0.63M 0.41M 0.41M
Short term debt 1.81M - 0.93M 0.22M -
Short long term debt - 1.81M 0.93M 0.27M 0.22M
Short long term debt total 1.81M - 0.93M 0.58M -
Other stockholder equity 4.88M - 4.64M 0.38M -
Property plant equipment - - 0.16M 0.11M 0.59M
Total current assets - 0.00M 0.30M 0.26M 0.26M
Net tangible assets - - -1.34M -0.31M 0.05M
Net receivables - - - 0.09M 0.09M
Long term debt - - - - 0.36M
Accounts payable 0.11M 0.11M 0.05M 0.06M 0.06M
Accumulated other comprehensive income 0.03M - - - -
Non currrent assets other -91.40M - 0.01M - -
Non current assets total 0.09M 0.09M 0.16M 0.59M 0.59M
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Investments - -0.13M -0.08M -0.11M -0.26M
Change to liabilities - - 0.01M 0.04M 0.00M
Total cashflows from investing activities -0.13M - -0.08M -0.11M -0.26M
Net borrowings - 0.60M 1.01M 0.05M 0.15M
Total cash from financing activities 0.60M 0.60M 1.07M 0.24M 0.24M
Change to operating activities - - 0.12M 0.04M 0.01M
Net income -4.76M -4.76M -2.70M -0.32M -0.32M
Change in cash -0.30M -0.30M 0.28M 0.00M -0.17M
Begin period cash flow 0.30M 0.30M 0.01M 0.17M 0.17M
End period cash flow - 0.30M 0.30M 0.17M 0.17M
Total cash from operating activities -0.76M -0.76M -0.71M 0.02M -0.15M
Issuance of capital stock - 0.00M 0.04M - -
Depreciation 0.06M 0.06M 0.04M 0.07M 0.01M
Other cashflows from investing activities -0.05M - - -0.07M -0.26M
Change to inventory - - - 0.01M -
Change to account receivables - - - -0.03M -0.03M
Other cashflows from financing activities -0.13M - 1.46M -39.68M 0.09M
Change to netincome - - 0.28M 3.11M 0.02M
Capital expenditures 0.08M 0.08M 0.08M 0.26M 0.04M
Change in working capital 0.30M 0.30M 0.13M 0.01M 0.01M
Stock based compensation 0.00M - 0.96M 0.04M 0.04M
Other non cash items 3.63M 2.11M 0.86M 0.25M 0.25M
Free cash flow -0.85M -0.85M -0.79M -0.23M -0.23M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
FORZ
Forza Innovations Inc
-
-%
0.00 - - 2.68 - 24.59 -0.74
ABT
Abbott Laboratories
-0.10
0.10%
103.87 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-
-%
100.61 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-0.13
0.04%
313.08 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
0.64
1.35%
48.14 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Forza Innovations Inc

Forza Innovations Inc. engages in the health-tech wearable performance business. It offers WarmUp series product line, including J4 Sport, J4 X, and J4 Fitbelt that are wearable back compression devices that are used to relax, warmup, loosen, or relax stiff and sore muscles. The company was formerly known as Genesys Industries, Inc. and changed its name to Forza Innovations Inc. in June 2021. Forza Innovations Inc. was incorporated in 2014 and is based in San Diego, California.

406 9th Avenue, San Diego, CA, United States, 92101

(702) 205-2064

2

Name Title Year Born
Mr. Johnny M. Forzani Founder, Pres, CEO, CFO, Treasurer, Sec. & Director 1948
Mr. Evan Schick Head of Corp. Fin. NA
Mr. Johnny M. Forzani Founder, President, CEO, CFO, Treasurer, Secretary & Director 1948
Mr. Evan Schick Head of Corporate Finance NA
Mr. Mark Dockery Vice President of Development & Communications NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…